Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. The use of this class of medications is currently limited to venous thromboembolic therapy and prophylaxis, in addition to s...
Saved in:
Main Authors: | Sherif Elhosseiny, Hassan Al Moussawi, Jean M. Chalhoub, James Lafferty, Liliane Deeb |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2019/4383269 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
Predictors of direct oral anticoagulant concentrations in the trauma population
by: Laura Adams, et al.
Published: (2024-05-01) -
Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01) -
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
by: Dana Prídavková, et al.
Published: (2019-01-01) -
Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
by: Kimberley Doucette, et al.
Published: (2020-01-01)